Journal Watch · Frontiers in Immunology · 2026

Combination of albumin-lymphocyte score and skeletal muscle index predicts prognosis of patients with ovarian cancer after primary debulking surgery.

These findings were validated in an independent cohort study.<h4>Conclusion</h4>The CAS grade, a combination of ALS and SMI, is a meaningful and independent predictor of prognosis in patients with OC.

Chen Y, Kang Q, Nie D et al.Frontiers in Immunology3 min readPharma relevance 55/100

DOI: 10.3389/fimmu.2026.1781291PMID: 42064053Study type: cohort / observational clinical study

TL;DR

These findings were validated in an independent cohort study.<h4>Conclusion</h4>The CAS grade, a combination of ALS and SMI, is a meaningful and independent predictor of prognosis in patients with OC.

Key findings

  • Upon stratification by CAS grade, grade 1 patients demonstrated the highest body mass index and the most favorable survival prognosis, whereas grade 3 patients demonstrated the poorest OS and RFS.
  • The independent variables for OS and RFS included residual disease and elevated CAS grade.
  • These findings were validated in an independent cohort study.<h4>Conclusion</h4>The CAS grade, a combination of ALS and SMI, is a meaningful and independent predictor of prognosis in patients with OC.

What they did

The patients were divided into discovery (237 patients) and validation (110 patients) cohorts. Serological tests and plain computed tomography were performed to quantify the ALS and SMI. We investigated the preoperative prognostic ability of a unique index based on a combination of ALS and SMI, the CAS grade.<h4>Results</h4>Patients with a lower ALS and a higher SMI showed improved overall survival (OS) and recurrence-free survival (RFS).

Full abstract (original)

Background: <h4>Purpose</h4>Accumulating evidence underscores the significance of inflammation and nutrition in tumor progression. Although low albumin-lymphocyte score (ALS) and skeletal muscle index (SMI) are known to be associated with negative outcomes in patients with ovarian cancer (OC) undergoing primary debulking surgery, the usefulness for predicting prognosis remains unclear. We aimed to assess the relevant preoperative prognostic variables and their combined impact on patients with OC.<h4>Methods</h4>This retrospective study included 347 patients with primary OC from multiple medical centers.

What they did: The patients were divided into discovery (237 patients) and validation (110 patients) cohorts. Serological tests and plain computed tomography were performed to quantify the ALS and SMI. We investigated the preoperative prognostic ability of a unique index based on a combination of ALS and SMI, the CAS grade.<h4>Results</h4>Patients with a lower ALS and a higher SMI showed improved overall survival (OS) and recurrence-free survival (RFS).

Results & conclusions: Upon stratification by CAS grade, grade 1 patients demonstrated the highest body mass index and the most favorable survival prognosis, whereas grade 3 patients demonstrated the poorest OS and RFS. The independent variables for OS and RFS included residual disease and elevated CAS grade. These findings were validated in an independent cohort study.<h4>Conclusion</h4>The CAS grade, a combination of ALS and SMI, is a meaningful and independent predictor of prognosis in patients with OC.

Abstract © the authors / Frontiers in Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.3389/fimmu.2026.1781291 · PubMed 42064053.

Why it matters for pharma & biotech

  • Relevant to Immunology teams tracking Frontiers in Immunology for new targets, mechanisms and biomarkers.
  • Because it reports human data, it can inform indication, endpoint and comparator decisions faster than preclinical work.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Frontiers in Immunology study find?

These findings were validated in an independent cohort study.<h4>Conclusion</h4>The CAS grade, a combination of ALS and SMI, is a meaningful and independent predictor of prognosis in patients with OC.

What type of study is this?

It is a cohort / observational clinical study, published in Frontiers in Immunology in 2026. The patients were divided into discovery (237 patients) and validation (110 patients) cohorts.

Where can I read the original paper?

The original is at the publisher via DOI 10.3389/fimmu.2026.1781291. PubMed ID: 42064053. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Chen Y, Kang Q, Nie D et al.. Combination of albumin-lymphocyte score and skeletal muscle index predicts prognosis of patients with ovarian cancer after primary debulking surgery.. Frontiers in Immunology (2026). DOI: 10.3389/fimmu.2026.1781291.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/combination-of-albumin-lymphocyte-score-and-skeletal-muscle-index-predic-781291/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides